BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28646443)

  • 1. Recent Discoveries in Monogenic Disorders of Childhood Bone Fragility.
    Mäkitie RE; Kämpe AJ; Taylan F; Mäkitie O
    Curr Osteoporos Rep; 2017 Aug; 15(4):303-310. PubMed ID: 28646443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Kämpe AJ; Costantini A; Mäkitie RE; Jäntti N; Valta H; Mäyränpää M; Kröger H; Pekkinen M; Taylan F; Jiao H; Mäkitie O
    Osteoporos Int; 2017 Oct; 28(10):3023-3032. PubMed ID: 28748388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Genetic Forms of Childhood-Onset Primary Osteoporosis.
    Kämpe AJ; Mäkitie RE; Mäkitie O
    Horm Res Paediatr; 2015; 84(6):361-9. PubMed ID: 26517534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations.
    Palomo T; Al-Jallad H; Moffatt P; Glorieux FH; Lentle B; Roschger P; Klaushofer K; Rauch F
    Bone; 2014 Oct; 67():63-70. PubMed ID: 25010833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations.
    Kannu P; Mahjoub A; Babul-Hirji R; Carter MT; Harrington J
    Horm Res Paediatr; 2017; 88(3-4):298-304. PubMed ID: 28605746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in
    Brlek P; Antičević D; Molnar V; Matišić V; Robinson K; Aradhya S; Krpan D; Primorac D
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
    Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
    J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel frameshift deletion in PLS3 causing severe primary osteoporosis.
    Costantini A; Krallis PΝ; Kämpe A; Karavitakis EM; Taylan F; Mäkitie O; Doulgeraki A
    J Hum Genet; 2018 Aug; 63(8):923-926. PubMed ID: 29884797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis.
    Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O
    J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation.
    van de Laarschot DM; Zillikens MC
    Bone; 2016 Oct; 91():148-51. PubMed ID: 27477003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1.
    Verdonk SJE; Storoni S; Zhytnik L; Zhong W; Pals G; van Royen BJ; Elting MW; Maugeri A; Eekhoff EMW; Micha D
    Calcif Tissue Int; 2023 Aug; 113(2):186-194. PubMed ID: 37277619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.
    Laine CM; Wessman M; Toiviainen-Salo S; Kaunisto MA; Mäyränpää MK; Laine T; Pekkinen M; Kröger H; Välimäki VV; Välimäki MJ; Lehesjoki AE; Mäkitie O
    J Bone Miner Res; 2015 Mar; 30(3):510-8. PubMed ID: 25209159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.
    Fahiminiya S; Majewski J; Al-Jallad H; Moffatt P; Mort J; Glorieux FH; Roschger P; Klaushofer K; Rauch F
    J Bone Miner Res; 2014 Aug; 29(8):1805-14. PubMed ID: 24616189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights Into Monogenic Causes of Osteoporosis.
    Mäkitie RE; Costantini A; Kämpe A; Alm JJ; Mäkitie O
    Front Endocrinol (Lausanne); 2019; 10():70. PubMed ID: 30858824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLS3 mutations in X-linked osteoporosis with fractures.
    van Dijk FS; Zillikens MC; Micha D; Riessland M; Marcelis CL; de Die-Smulders CE; Milbradt J; Franken AA; Harsevoort AJ; Lichtenbelt KD; Pruijs HE; Rubio-Gozalbo ME; Zwertbroek R; Moutaouakil Y; Egthuijsen J; Hammerschmidt M; Bijman R; Semeins CM; Bakker AD; Everts V; Klein-Nulend J; Campos-Obando N; Hofman A; te Meerman GJ; Verkerk AJ; Uitterlinden AG; Maugeri A; Sistermans EA; Waisfisz Q; Meijers-Heijboer H; Wirth B; Simon ME; Pals G
    N Engl J Med; 2013 Oct; 369(16):1529-36. PubMed ID: 24088043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties.
    Balasubramanian M; Fratzl-Zelman N; O'Sullivan R; Bull M; Fa Peel N; Pollitt RC; Jones R; Milne E; Smith K; Roschger P; Klaushofer K; Bishop NJ
    Am J Med Genet A; 2018 Jul; 176(7):1578-1586. PubMed ID: 29736964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis.
    Peris P; Monegal A; Mäkitie RE; Guañabens N; González-Roca E
    Osteoporos Int; 2023 Feb; 34(2):405-411. PubMed ID: 36396825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in WNT1 cause different forms of bone fragility.
    Keupp K; Beleggia F; Kayserili H; Barnes AM; Steiner M; Semler O; Fischer B; Yigit G; Janda CY; Becker J; Breer S; Altunoglu U; Grünhagen J; Krawitz P; Hecht J; Schinke T; Makareeva E; Lausch E; Cankaya T; Caparrós-Martín JA; Lapunzina P; Temtamy S; Aglan M; Zabel B; Eysel P; Koerber F; Leikin S; Garcia KC; Netzer C; Schönau E; Ruiz-Perez VL; Mundlos S; Amling M; Kornak U; Marini J; Wollnik B
    Am J Hum Genet; 2013 Apr; 92(4):565-74. PubMed ID: 23499309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.
    Kämpe AJ; Costantini A; Levy-Shraga Y; Zeitlin L; Roschger P; Taylan F; Lindstrand A; Paschalis EP; Gamsjaeger S; Raas-Rothschild A; Hövel M; Jiao H; Klaushofer K; Grasemann C; Mäkitie O
    J Bone Miner Res; 2017 Dec; 32(12):2394-2404. PubMed ID: 28777485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.